NEUROCRINE BIOSCIENCES, INC. Quotes Neurocrine Biosciences, Inc. Deutsche Boerse AG
Equities
NB3
US64125C1099
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 125.1 EUR | +0.85% |
|
-3.29% | +5.09% |
| May. 31 | Neurocrine Biosciences Insider Sold Shares Worth $5,338,565, According to a Recent SEC Filing | MT |
| May. 28 | Neurocrine Biosciences Says CEO Kevin Gorman Retiring | MT |
Quotes 5-day view
Delayed Quote Deutsche Boerse AG| 2024-05-28 | 2024-05-29 | 2024-05-30 | 2024-05-31 | 2024-06-03 | |
|---|---|---|---|---|---|
| Last | 128.95 € | 125 € | 123.3 € | 124.05 € | 124.9 € |
| Volume | 280 | 12 | 0 | 60 | 95 |
| Change | -0.15% | -3.06% | -1.36% | +0.61% | +0.85% |
| Opening | 127.50 | 127.55 | 123.30 | 125.60 | 124.6 |
| High | 128.95 | 127.55 | 123.30 | 125.60 | 124.9 |
| Low | 127.50 | 125.00 | 123.30 | 124.05 | 124.6 |
Performance
| 1 day | +0.83% | ||
| 1 week | -3.29% | ||
| Current month | +0.69% | ||
| 1 month | -4.62% | ||
| 3 months | +2.21% | ||
| 6 months | +16.73% | ||
| Current year | +5.09% | ||
| 1 year | +45.95% | ||
| 3 years | +62.59% | ||
| 5 years | +66.80% | ||
| 10 years | +1,136.63% |
Volumes
marketsDaily volume
95
Estimated daily volume
335
Avg. Volume 20 sessions
40
Daily volume ratio
8.39
Avg. Volume 20 sessions
5 004.00
Avg. Volume 20 sessions USD
5 421.83
Record volume 1
16 570
Record volume 2
16 562
Record volume 3
16 219
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (EUR)
13 627 286 908
Capitalization (USD)
13 627 286 908
Net sales (USD)
1 887 100 000
Number of employees
1 448
Sales / Employee (USD)
1 303 246
Free-Float
98.2 %
Free-Float capitalization (EUR)
14 500 948 914
Free-Float capitalization (USD)
13 381 461 157
Average Daily Capital Traded
0%
Highs and lows
1 week
123.30
128.95
1 month
123.30136.00
Current year
118.25136.00
1 year
83.96136.00
3 years
63.54136.00
5 years
63.54136.00
10 years
9.35136.00
Indicators
Moving average 5 days
126.09
Moving average 20 days
129.10
Moving average 50 days
128.40
Moving average 100 days
126.67
Price spread / (MMA5)
+0.79%
Price spread / (MMA20)
+3.20%
Price spread / (MMA50)
+2.64%
Price spread / (MMA100)
+1.26%
STIM
RSI 9 days
31.48
RSI 14 days
38.62
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +0.85% | -3.29% | +5.09% | +45.95% | 13.63B | ||
| +1.01% | -0.49% | +11.60% | +32.46% | 106B | ||
| +1.89% | +3.76% | -4.68% | -6.96% | 24.28B | ||
| +0.53% | 0.00% | -0.29% | -8.50% | 21.96B | ||
| +1.55% | +0.74% | -8.61% | -28.20% | 18.16B | ||
| +0.41% | -1.50% | -42.12% | -37.93% | 16.37B | ||
| -3.53% | -2.53% | -17.47% | -34.53% | 15.56B | ||
| +4.38% | +5.12% | +34.58% | +3.69% | 12.27B | ||
| -3.39% | +150.23% | +77.64% | +181.73% | 8.87B | ||
| -1.75% | +3.60% | +7.26% | +47.97% | 7.75B | ||
| +0.01% | +2.20% | +11.89% | +38.52% | 7.65B | ||
| +0.34% | -1.43% | -3.92% | +22.05% | 7.42B | ||
| -7.68% | -3.38% | -33.51% | -36.87% | 7.29B | ||
| +0.74% | -0.78% | +234.55% | +179.44% | 6.87B | ||
| +4.30% | +5.47% | -9.57% | +13.05% | 6.32B | ||
| -20.61% | +156.95% | +232.76% | +379.83% | 6.1B | ||
| Average | -1.31% | +21.30% | +30.95% | +49.48% | ||
| Weighted average by Cap. | +0.07% | +8.84% | +14.02% | +27.54% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
9a5.QlOyzeFAbt0dHzcFZmmwx1hKWuPpN7mZioZs_02ngnQ.DSLwqswiPJNvUnJpHCHFoypnd7CLb8HBwdAal37gs1klPt-dkBUmmm1Sdg
| Date | Price | Volume | Daily volume |
|---|
Monthly variations
Annual change
| 2024 | +4.38% | ||
| 2023 | +6.17% | ||
| 2022 | +51.52% | ||
| 2021 | -2.61% | ||
| 2020 | -22.77% | ||
| 2019 | +61.25% | ||
| 2018 | -3.11% | ||
| 2017 | +75.26% | ||
| 2016 | -29.23% | ||
| 2015 | +177.23% | ||
| 2014 | +171.25% | ||
| 2013 | +20.31% | ||
| 2012 | -14.85% | ||
| 2011 | +13.00% | ||
| 2010 | +191.10% | ||
| 2009 | -16.67% | ||
| 2008 | -20.00% | ||
| 2007 | -61.73% | ||
| 2006 | -85.14% | ||
| 2005 | +46.53% | ||
| 2004 | -17.88% | ||
| 2003 | -2.58% | ||
| 2002 | -24.11% | ||
| 2001 | +56.88% | ||
| 2000 | +23.93% |
- Stock Market
- Equities
- NBIX Stock
- NB3 Stock
- Quotes Neurocrine Biosciences, Inc.
